Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury

NCT01251367 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT01251367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01251367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Lead sponsor
Ipsen
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2011
Completion date
April 30, 2015
Enrollment
352 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

post-stroke spasticity, spasticity post-traumatic brain injury